Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT04849585
  4. Details
NCT04849585 Clinical Trial

Evaluation of the Impact of Hospitalization in Intensive Care for COVID-19 Infection

Covid19 Clinical Trial

— POSTREACOVID  

Official title:
Evaluation of the Impact of Hospitalization in Intensive Care for COVID-19 Infection

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT04849585
Other study ID # RIPH_2020_11
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 2022
Est. completion date February 2023

Study information
Verified date May 2022
Source Tourcoing Hospital
Contact Pauline THILL, MD
Phone 0320694949
Email pthill@ch-tourcoing.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To evaluate the psychological, physical, social, professional and family impact of a hospitalization in intensive care for a covid 19 by analysis of the verbatim during a semi-structured interview.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 40
Est. completion date February 2023
Est. primary completion date December 2022
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All patients hospitalized in intensive care at CH Dron for a COVID 19 who have given their agreement during their follow-up consultation Exclusion Criteria: - Minor patient - Patient does not speak French - Refusal to participate

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• semi-directed entretien
semi-directed entretien

Locations
Country Name City State
France CH Tourcoing Tourcoing

Sponsors (1)
Lead Sponsor Collaborator
Tourcoing Hospital

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Psychological impact of hospitalization in intensive care for a covid 19. Frequency of recurring nightmares, irritability and anxious patient At day 1
Primary Physical impact of hospitalization in intensive care for a covid 19. Frequency of Handicap and resumption of professional and personal activities At day 1
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3